China SFDA publishes 2nd batch of cosmetic ingredients

By Michelle Yeomans

- Last updated on GMT

Related tags Cosmetic ingredients Cosmetics

China SFDA publishes 2nd batch of cosmetic ingredients
The China State Food and Drug Administration has published a second batch of ingredients for consultation in an inventory of existing cosmetic ingredients (IECIC).

In China, foreign manufacturers are required to register cosmetics before products are allowed on to the market, the government body must also determine whether there is a new, prohibited or restricted ingredient being registered.

According to regulatory specialist April Guo, the inventory is extremely important and will be completed in three batches, with the last to be published at the end of the year.

Second batch

There are 673 ingredients in the second batch of the inventory.  The first was revised in May and includes 1674 cosmetic ingredients.

As outlined by hygiene supervision over cosmetics (1990), the use of new ingredients for cosmetics production must be approved first. The rules for the application of administrative licenses for cosmetics (2009) have also clearly indicated that the use of new ingredient in cosmetics in China must be licensed.

Guo tells CosmeticsDesign-Europe.com that an ingredient will be regarded as ‘used’ if it is included in the IECIC in China (2003 or 2012) and is not a banned substance; has been used in a licensed special use cosmetic product; or is part of a plant that has been approved as cosmetic ingredient.

The table below highlights the progress since 2003.

IECIC 2003

IECIC 2012

 

  • 3265 cosmetic ingredients in total.
  • 2156 general ingredients;
  • 546 specific cosmetic ingredients;
  • 563 natural ingredients including traditional Chinese medicine;
  • Includes banned ingredients.
  • Only ingredient names are given.
  • 1674​ cosmetic ingredients(First Batch)+ 673​ ingredients(Second Batch);
  • More batches will be published;
  • Has removed banned ingredients;
  • Has indicated both the name and the maximum allowable dose level;

 

The deadline for comments on the second batch is the 15th​ of July.

 

Related topics Regulation & Safety Skin Care

Related news

Related products

show more

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers

Follow us

Products

View more

Podcast

Beauty 4.0 Podcast